Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    New June 2026 items include a dividend declaration, FDA approval of Pfizer’s IBRANCE regimen for HR+, HER2+ metastatic breast cancer frontline maintenance, and an investor webcast notice, plus a June 22 topline Phase 3 results release for Sigvotatug Vedotin in previously treated metastatic non-squamous non-small cell lung cancer; several May 2026 entries have been removed from the archive.
    Difference
    9%
    Check dated 2026-06-27T06:03:27.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A new leadership-related press release entry, 'Pfizer Announces Chief Financial Officer Transition' dated 06.18.2026, was added to the archive (under Leadership, with related navigation like Supplier & B2B Resources). The previously listed ELREXFIO press release from 04.29.2026 has been removed from the archive along with its associated categories (Prescription Medicines, April 2026, Business to Business).
    Difference
    1%
    Check dated 2026-06-20T04:45:26.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The press release archive now adds Research and Research and Pipeline categories and includes new items such as HYMPAVZI approval and Berobenatide dosing with dates, while removing older items from Finance/Corporate sections (e.g., shareholder meeting preliminary results and VYNDAMAX settlements).
    Difference
    3%
    Check dated 2026-06-13T00:18:57.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    New June 2026 and May 2026 press release entries have been added to the archive, including Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference and other May releases. A set of April 2026 items has been removed from the archive.
    Difference
    9%
    Check dated 2026-06-05T22:47:25.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Three new May 2026 press releases were added to the archive (05.29.2026 Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer; 05.28.2026 Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines; 05.27.2026 Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference). Additionally, several older March 2026 entries were removed from the archive as part of ongoing content updates.
    Difference
    9%
    Check dated 2026-05-29T22:51:00.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The archive adds Research and Research and Pipeline sections and a new May 20, 2026 press release title about a pediatric pneumococcal vaccine program; it also removes Finance and Financial categories and an older press item about a mini-tender offer.
    Difference
    1%
    Check dated 2026-05-22T16:55:29.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.